undamentalytics Newsletter
Sign in

Illumina, Inc. income statement

In fiscal 2025, Illumina, Inc. reported revenue of $4.34bn, down 0.7% on the year before, operating income of $807m (a 18.6% margin) and net income of $850m, or $5.45 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2009Jan 20102010Jan 20112011Jan 20122012Dec 20122013Dec 20132014Dec 20142015Jan 20162016Jan 20172017Dec 20172018Dec 20182019Dec 20192020Jan 20212021Jan 20222022Jan 20232023Dec 20232024Dec 20242025Dec 2025LTMSept 2026
Revenue6669031,0561,1491,4211,8612,2202,3982,7523,3333,5433,2394,5264,5844,5044,3724,3434,538
Cost of revenue2123013463755095646717329261,0331,0761,0361,3721,6121,7601,5111,4731,458
Gross profit4546027097749121,2981,5491,6661,8262,3002,4672,2033,1542,9722,7442,8612,8703,080
Research and development1411781972312773884015045466236476821,1851,3211,3541,169967975
Selling, general and administrative1762202622863814665165846747948359412,0921,2971,6121,0921,0861,135
Operating income126212199201134515613587606883985580−123−4,179−1,069−833807960
Interest expense24253538404243333757524961267710010198
Income before tax1141851332231594495835611,0438941,118856884−4,336−1,117−1,1791,0861,058
Income tax426046713495125133365112128200122684444236163
Net income72125871511253534624637268261,002656762−4,404−1,161−1,223850895
Diluted EPS$0.52$0.87$0.62$1.13$0.90$2.37$3.10$3.07$4.92$5.56$6.74$4.45$5.04−$28.00−$7.34−$7.69$5.45$5.82
Diluted shares (average)141m147m143m137m144m153m153m152m152m153m153m152m155m157m158m159m156m154m
EBITDA1502462552491856277407287621,0621,173767128−3,785−637−4791,0771,180

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: ILMN vs WATILMN vs MTDCRL vs ILMN

More: Life Sciences Tools & Services stocks compared, Health Care sector, rankings of US companies

Figures from Illumina, Inc.'s SEC filings (10-K and 10-Q), retrieved October 30, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Illumina, Inc.